These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24615188)

  • 1. Role of brachytherapy in the treatment of cancers of the anal canal. Long-term follow-up and multivariate analysis of a large monocentric retrospective series.
    Lestrade L; De Bari B; Pommier P; Montbarbon X; Lavergne E; Ardiet JM; Carrie C
    Strahlenther Onkol; 2014 Jun; 190(6):546-54. PubMed ID: 24615188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose-rate interstitial brachytherapy boost for the treatment of anal canal cancers.
    Cordoba A; Escande A; Leroy T; Mirabel X; Coche-Dequéant B; Lartigau E
    Brachytherapy; 2017; 16(1):230-235. PubMed ID: 27600606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with split-course external beam irradiation +/- chemotherapy and integrated Ir-192 high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal.
    Kapp KS; Geyer E; Gebhart FH; Oechs AC; Berger A; Hebenstreit J; Stoeger H
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):997-1005. PubMed ID: 11240240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Conservative treatment of anal canal carcinoma with external radiotherapy and interstitial brachytherapy, with or without chemotherapy: long-term results].
    Berger C; Félix-Faure C; Chauvet B; Vincent P; Alfonsi M; Coudurier P; Plat F; Reboul F
    Cancer Radiother; 1999; 3(6):461-7. PubMed ID: 10630158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoradiotherapy with Brachytherapy or Electron Therapy Boost for Locally Advanced Squamous Cell Carcinoma of the Anus-Reducing the Colostomy Rate.
    Kent C; Bessell EM; Scholefield JH; Chappell S; Marsh L; Mills J; Sayers I
    J Gastrointest Cancer; 2017 Mar; 48(1):1-7. PubMed ID: 27412395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients.
    Gerard JP; Ayzac L; Hun D; Romestaing P; Coquard R; Ardiet JM; Mornex F
    Radiother Oncol; 1998 Mar; 46(3):249-56. PubMed ID: 9572617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancers.
    Varela Cagetti L; Zemmour C; Salem N; Minsat M; Ferrè M; Mailleux H; Giovaninni M; Lelong B; De Chaisemartin C; Ries P; Poizat F; Tallet A; Moureau-Zabotto L
    Brachytherapy; 2019; 18(6):814-822. PubMed ID: 31515067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservative treatment by irradiation of epidermoid cancers of the anal canal: prognostic factors of tumoral control and complications.
    Peiffert D; Bey P; Pernot M; Guillemin F; Luporsi E; Hoffstetter S; Aletti P; Boissel P; Bigard MA; Dartois D; Baylac F
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):313-24. PubMed ID: 9069302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of brachytherapy in the boost management of anal carcinoma with node involvement (CORS-03 study).
    Moureau-Zabotto L; Ortholan C; Hannoun-Levi JM; Teissier E; Cowen D; Salem N; Lemanski C; Ellis S; Resbeut M
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e135-42. PubMed ID: 23195780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes after intensity-modulated compared with 3-dimensional conformal radiotherapy with chemotherapy for squamous cell carcinoma of the anal canal.
    Agarwal MS; Hitchcock KE; Morris CG; George TJ; Mendenhall WM; Zlotecki RA
    Curr Oncol; 2019 Aug; 26(4):e515-e521. PubMed ID: 31548820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial high-dose rate brachytherapy as boost for anal canal cancer.
    Falk AT; Claren A; Benezery K; François E; Gautier M; Gerard JP; Hannoun-Levi JM
    Radiat Oncol; 2014 Nov; 9():240. PubMed ID: 25377886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiochemotherapy and brachytherapy could be the standard treatment for anal canal cancer in elderly patients? A retrospective single-centre analysis.
    Lestrade L; De Bari B; Montbarbon X; Pommier P; Carrie C
    Med Oncol; 2013 Mar; 30(1):402. PubMed ID: 23322520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The anal canal: 2 cycles of radiochemotherapy and boost brachytherapy].
    Valentini V; Mantello G; Luzi S; Genovesi D; Smaniotto D; Mantini G; Coco C; Ratto C; Sofo L; Cellini N
    Radiol Med; 1997 Apr; 93(4):451-6. PubMed ID: 9244925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidermoid carcinomas of the anal canal treated with definitive radiation therapy in a series of 305 patients].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Huang R; Qu SH; Pène F; Schlienger M
    Cancer Radiother; 2003 Aug; 7(4):237-53. PubMed ID: 12914857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-year experience in the management of squamous cell anal canal carcinoma with interstitial brachytherapy.
    López Guerra JL; Lozano AJ; Pera J; Gutiérrez C; Cambray M; Ferrer F; Guedea F
    Clin Transl Oncol; 2011 Jul; 13(7):472-9. PubMed ID: 21775274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for early and late local toxicities in anal cancer treated by radiotherapy in combination with or without chemotherapy.
    Doyen J; Benezery K; Follana P; Ortholan C; Gérard JP; Hannoun-Levi JM; Gal J; Francois E
    Dis Colon Rectum; 2013 Oct; 56(10):1125-33. PubMed ID: 24022529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
    Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
    Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer.
    Chapet O; Gerard JP; Riche B; Alessio A; Mornex F; Romestaing P
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1316-24. PubMed ID: 16169674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy.
    Ortholan C; Ramaioli A; Peiffert D; Lusinchi A; Romestaing P; Chauveinc L; Touboul E; Peignaux K; Bruna A; de La Roche G; Lagrange JL; Alzieu C; Gerard JP
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):479-85. PubMed ID: 15890590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.